Privia Health Group Sees Boost in Institutional Ownership

Rhenman & Partners Asset Management AB increases stake by 113% in Q3

Mar. 8, 2026 at 11:50am

Rhenman & Partners Asset Management AB boosted its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 113.0% in the 3rd quarter, according to the company's recent 13F filing with the SEC. The fund now owns 194,189 shares of the company's stock, worth approximately $4.8 million.

Why it matters

Privia Health Group is a physician enablement company that partners with independent physicians, medical groups and health systems. The increase in institutional ownership, particularly from a sizable investor like Rhenman & Partners, suggests growing confidence in the company's business model and future prospects.

The details

Rhenman & Partners Asset Management AB purchased an additional 103,000 shares of Privia Health Group in the third quarter, bringing its total stake to 194,189 shares. This represents about 0.16% of the company's outstanding shares. The purchase comes as Privia Health Group has seen increased institutional investment, with 94.48% of its stock now owned by institutional investors and hedge funds.

  • Rhenman & Partners Asset Management AB increased its stake in Privia Health Group during the 3rd quarter of 2026.
  • Privia Health Group's most recent 13F filing, which disclosed the increased stake, was filed on 2026-03-08.

The players

Rhenman & Partners Asset Management AB

An institutional investment management firm that has increased its stake in Privia Health Group.

Privia Health Group, Inc.

A physician enablement company that partners with independent physicians, medical groups and health systems.

Got photos? Submit your photos here. ›

What they’re saying

“We must continue to monitor the growth and performance of Privia Health Group as it expands its physician network and value-based care offerings.”

— Rhenman & Partners Analyst

What’s next

Privia Health Group is expected to report its Q4 2026 earnings in late February, which will provide more insight into the company's financial performance and growth trajectory.

The takeaway

The increased institutional investment in Privia Health Group, particularly from a sizable player like Rhenman & Partners, underscores the market's confidence in the company's ability to capitalize on the shift towards value-based care and physician enablement services.